98%
921
2 minutes
20
Background: Platelet concentrates have been used in tissue regeneration. The purpose of this study was to examine effects of growth factors released from leukocyte- and platelet-rich fibrin (L-PRF) and concentrated growth factor (CGF) on the osteogenic differentiation of periodontal ligament fibroblasts (PDLFs).
Methods: Leukocyte- and platelet-rich fibrins, CGFs and PDLFs were obtained from New Zealand rabbits. The release of basic fibroblast growth factor (bFGF), bone morphogenetic protein 2 (BMP-2) and transforming growth factor β1 (TGF-β1) from L-PRFs and CGFs was measured at 5 h and 1, 3, 5, 7 days, using the enzyme linked immunosorbent assay. The PDLFs were treated with exudates of L-PRF or CGF. After the treatment, cell counting kit-8 assay was performed at day 1, 3, 5 and 7. Alkaline phosphatase (ALP) assay and Western blotting were applied at day 7. Three blocking antibodies were used to neutralize the proteins of bFGF, BMP-2 and TGF-β1.
Results: Leukocyte- and platelet-rich fibrin and CGF showed different growth factor release pattern, but similar accumulated concentration of these growth factors. PDLFs proliferation was significantly promoted by both L-PRF and CGF at day 1, 3 and 7, and CGF group was superior to L-PRF group at day 1 and 3. Both L-PRF and CGF significantly enhanced PDLFs ALP activity and protein expression of osteogenic markers. The osteopontin level was higher in CGF group than in L-PRF group, but no significant differences were found between two groups for ALP activity. Three blocking antibodies significantly downregulated both L-PRF and CGF induced osteogenic markers expression.
Conclusion: Both CGF and L-PRF can promote the proliferation and osteogenic differentiation of PDLFs. The bFGF, BMP-2 and TGF-β1 are involved in both L-PRF and CGF induced osteogenic differentiation of PDLFs.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825745 | PMC |
http://dx.doi.org/10.7717/peerj.7984 | DOI Listing |
Front Bioeng Biotechnol
August 2025
Department of Plastic Surgery, ZhongshanCity People's Hospital, Zhongshan, Guangdong, China.
Platelet concentrates (PCs) have evolved from classical formulations to exosome-based therapies, reflecting a paradigm shift in regenerative medicine. This review analyzes three generations of PCs products, comparing their technological progress, functional differences, and clinical applications. It proposes a novel function-driven classification system that redefines PCs generations based on biological activity rather than chronological development.
View Article and Find Full Text PDFJ Dent Res Dent Clin Dent Prospects
June 2025
Dental Sciences Research Center, School of Dentistry, Guilan University of Medical Sciences, Rasht, Iran.
Background: This study was designed to compare the effect of platelet-rich fibrin (PRF) and concentrated growth factor (CGF) on the immediate implants placed in previously infected sites.
Methods: A total of 210 patients were included in this randomized clinical trial. The remaining tooth was extracted, and the periapical lesion was removed.
J Mater Chem B
July 2025
School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, P. R. China.
Correction for 'Construction and evaluation of platelet concentrate/mesoporous bioactive glass composite scaffolds for bone repair: injectable platelet-rich fibrin (i-PRF) concentrated growth factors (CGF)' by Yuanyuan Guo , , 2025, https://doi.org/10.1039/D5TB00413F.
View Article and Find Full Text PDFJ Mater Chem B
July 2025
School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, 200093, P. R. China.
Rapid repair and functional reconstruction of maxillofacial bone defects is a significant challenge in the field of stomatology. Artificial bone substitute materials show promising potential in maxillofacial bone regeneration. This study investigated the bone regenerative effects of platelet concentrate/mesoporous bioactive glass (MBG) composite scaffolds, comparing injectable platelet-rich fibrin (i-PRF) and gel-phase concentrated growth factors (gpCGF).
View Article and Find Full Text PDFInt J Mol Sci
May 2025
Department of Periodontal Diseases and Oral Mucosa Diseases, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Pl. Traugutta 2, 41-800 Zabrze, Poland.
The rising prevalence of antibiotic resistance underscores the need for localized drug delivery systems that minimize systemic exposure. Autologous platelet concentrates (APCs), including concentrated platelet-rich fibrin (c-PRF) and liquid-phase concentrated growth factors (LPCGFs), have emerged as potential carriers for antimicrobial agents. This study aimed to evaluate the efficacy of c-PRF and LPCGF as carriers for three antibiotic formulations-amoxicillin with clavulanic acid, clindamycin, and a combination of amoxicillin with metronidazole-against methicillin-sensitive (MSSA), methicillin-resistant (MRSA), and (low-level natural resistance).
View Article and Find Full Text PDF